FDA Approved: BORTEZOMIB — Original Application (Dr.Reddy's Laboratories, Inc.)

View source ↗

Summary

FDA approval of Dr. Reddy's Laboratories' original ANDA for Bortezomib, enabling a generic version of the proteasome inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)